Convert VitaFOXO VITAFOXO to Solar SXP

This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.

Solar is a Layer 1 blockchain network secured by 53 Block Producers through Delegated Proof of Stake (DPoS) consensus, with SXP as its native utility coin. The network's security and governance are maintained through a system where coin holders can participate by voting for Block Producers. As an open, community-driven ecosystem, Solar enables collaboration between Block Producers and coin holders, fostering continuous development and enhancing the network's infrastructure. To bridge blockchain technology with traditional business needs, Solar Enterprises, established through funding from the Solar Blockchain Foundation, focuses on developing these consumer-oriented products and services. Current development includes an innovative crypto-first e-SIM solution aimed at international travellers.